
[Federal Register Volume 76, Number 153 (Tuesday, August 9, 2011)]
[Proposed Rules]
[Page 48751]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-20126]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 573

[Docket No. FDA-2011-F-0549]


Lanxess Corp.; Filing of Food Additive Petition (Animal Use); 
Calcium Formate

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of petition.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that 
Lanxess Corp. has filed a petition proposing that the food additive 
regulations be amended to provide for the safe use of calcium formate 
in poultry and swine feed as a nutrient and digestive aid.

DATES: Submit either electronic or written comments on the petitioner's 
environmental assessment by September 8, 2011.

ADDRESSES: Submit electronic comments to: http://www.regulations.gov. 
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Isabel W. Pocurull, Center for 
Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., 
Rockville, MD 20855, 240-453-6853, e-mail: isabel.pocurull@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), notice is given that a 
food additive petition (FAP 2261) has been filed by Lanxess Corp. 
(Lanxess), 111 RIDC Park West Dr., Pittsburgh, PA 15275-1112. The 
petition proposes to amend the food additive regulations in part 573 
Food Additives Permitted in Feed and Drinking Water of Animals (21 CFR 
part 573) to provide for the safe use of calcium formate in poultry and 
swine feed as a nutrient and digestive aid.
    The potential environmental impact of this action is being 
reviewed. To encourage public participation consistent with regulations 
issued under the National Environmental Policy Act (40 CFR 1501.4(b)), 
the Agency is placing the environmental assessment submitted with the 
petition that is the subject of this notice on public display at the 
Division of Dockets Management (see DATES and ADDRESSES) for public 
review and comment.
    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) either electronic or written comments regarding this 
document. It is only necessary to send one set of comments. It is no 
longer necessary to send two copies of mailed comments. Identify 
comments with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday. FDA will 
also place on public display any amendments to, or comments on, the 
petitioner's environmental assessment without further announcement in 
the Federal Register. If, based on its review, the Agency finds that an 
environmental impact statement is not required, and this petition 
results in a regulation, the notice of availability of the Agency's 
finding of no significant impact and the evidence supporting that 
finding will be published with the regulation in the Federal Register 
in accordance with 21 CFR 25.51(b).

    Dated: August 3, 2011.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2011-20126 Filed 8-8-11; 8:45 am]
BILLING CODE 4160-01-P


